Video

Dr. Perez on her Anticipated Results for ASCO and SABCS

Author(s):

Edith A. Perez, MD,

In Partnership With:

Edith A. Perez, MD, Director of Breast Program and Professor of Medicine, Mayo Clinic on her Anticipated Results for ASCO and SABCS

Related Videos
Grzegorz S. Nowakowski, MD
John Seymour, MBBS, FRACP, PhD
Sagar Lonial, MD, FACP
Sandip P. Patel, MD
Bradley McGregor, MD, director, clinical research, Lank Center for Genitourinary Oncology, Marra Lochiatto Investigator, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Moshe Ornstein, MD, MA, medical oncologist, Department of Hematology and Medical Oncology, Cleveland Clinic
Reid Merryman, MD
Partow Kebriaei, MD
John K. Lee, MD, PhD
Jean L. Koff, MD, MS
Related Content
The OncFive: Top Oncology Articles for the Week of 8/25
August 31st 2024

The OncFive: Top Oncology Articles for the Week of 8/25

MedNews Week
September 4th 2024

Park and Graff Explore the Evolving Role of CDK4/6 Inhibitors in Metastatic Breast Cancer

State of the Science Summit - Breast Cancer: Chaired by Christos Vaklavas, MD
August 29th 2024

State of the Science Summit - Breast Cancer: Chaired by Christos Vaklavas, MD

Komal Jhaveri, MD, FACP, section head, Endocrine Therapy Research Program, clinical director, Early Drug Development Service, Patricia and James Cayne Chair for Junior Faculty, Memorial Sloan Kettering Cancer Center
August 22nd 2024

Jhaveri on the INAVO120 Trial of Inavolisib/Palbociclib/Fulvestrant in PIK3CA -Mutant, HR+ Breast Cancer

Shipra Gandhi, MD
August 26th 2024

CDK4/6 Inhibitors, ADCs, and PI3K Inhibitors Individualize HR+ Breast Cancer Management

Bruce G. Haffty, MD, MS
August 25th 2024

NSABP B-51 Data Highlight Evolving Role of Radiation in Early-Stage Breast Cancer